Sumi Kapital ApS: Financial statements 2022
CVR: 41417196
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Sumi Kapital ApS (CVR 41417196) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 55,449 and a net result of DKK 41,357 compared with DKK -30,403 the year before. Equity in the 2022 report amounted to DKK 406,712. The solvency ratio was 90.4%.
- Gross Profit
- DKK 55,449
- Profit/Loss
- DKK 41,357
- Equity
- DKK 406,712
- Total Assets
- DKK 449,935
Official annual report
Keep an eye on Sumi Kapital ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of September 22, 2022, Niels Lomborg has joined the board of directors of Sumi Kapital ApS.
As of September 22, 2022, Mogens Sønderup has joined the board of directors of Sumi Kapital ApS.
As of September 22, 2022, Allan Sandbeck is registered as director of Sumi Kapital ApS.
As of September 22, 2022, Mikkel Sønderup is registered as director of Sumi Kapital ApS.
As of September 22, 2022, Mogens Sønderup has stepped down as director of Sumi Kapital ApS.
As of September 21, 2022, Niels Lomborg has left the board of directors of Sumi Kapital ApS.
Sumi Kapital ApS has published its annual report for 2021. Gross profit came to DKK -19,807, and the net result was DKK -30,403.
About Sumi Kapital ApS
Sumi Kapital ApS is a Danish company of the type Anpartsselskab based in Aarhus C, founded in 2020. The company is registered under the industry Investering for egen regning. The company was previously named DNA HUMAN DIAGNOSTIC A/S. The management consists of Mikkel Sønderup. The company is owned by SUMI HOLDING ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -22,276 and a net result of DKK -3,157 compared with DKK 17,958 the year before. Equity in the 2025 report amounted to DKK 432,540.
